Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.55 USD | -4.93% | +3.58% | +14.92% |
09/05 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
08/05 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.92% | 56Cr | |
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.34TCr | |
-1.69% | 2.18TCr | |
-10.60% | 1.81TCr | |
-41.25% | 1.67TCr | |
-15.33% | 1.6TCr | |
+5.80% | 1.4TCr | |
+28.03% | 1.17TCr |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- Transcript : IGM Biosciences, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 05